Bone quality assessed by phalangeal quantitative ultrasonography in children and adolescents with isolated idiopathic growth hormone deficiency

Journal of Endocrinological Investigation

Volumn 30, Issue 6, 2007, Pages 445-450

  Vignolo, M ^a   Di Battista, E ^a   Parodi, A ^a   Torrisi, C ^a   De Terlizzi, C ^b   Aicardi, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b IGEA Biophysics Laboratory   (Italy)

Author keywords

Bone quality; Children; GH treatment; Growth hormone; Quantitative ultrasound technique; QUS

Indexed keywords

ARGININE; CLONIDINE; GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY SIZE; BODY WEIGHT; BONE AGE; BONE MASS; BONE MATURATION; CHILD; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHALANX; PREDICTION; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 34848910132     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346326     Document Type: Article

References (18)

1. Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency. J Clin Endocrinol Metab 1998, 83: 3150-4.
2. Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Tato L. Bone development during GH and GnRH analog treatment. Eur J Endocrinol 2004, 151 Suppl 1: S47-54.
3. Maheshwari HG, Bouillon R, Nijs J, Oganov VS, Bakulin AV, Baumann G. The impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency. J Clin Enclocrinol Metab 2003, 88: 2614-8.
4. Wuster C, Abs R, Bengtsson BA, et al. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001, 16: 398-405.
5. Hogler W, Briody J, Moore B, Lu PW, Cowell CT. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic, short stature and growth hormone deficiency. Bone 2005, 37: 642-50.
6. Barkmann R, Lusse S, Stampa B, Sakata S, Heller M, Gluer CC. Assessment of the geometry of human finger phalanges using quantitative ultrasound in vivo. Osteoporos Int 2000, 11: 745-55.
7. Pluskiewicz W, Luszczynska A, Halaba Z, Drozdzowska B, Sonta-Jakimczyk D. Skeletal status in survivors of childhood acute lymphoblastic leukemia assessed by quantitative ultrasound: a pilot cross-sectional study. Ultrasound Med Biol 2002, 28: 1279-84.
8. Saggese G, Cesaretti G. Criteria for recognition of the growth-inefficient child who may respond to treatment with growth hormone. Am J Dis Child 1989, 143: 1287-91
9. Pollitzer WS, Anderson JJ. Ethnic and genetic differences in bone mass: a review with a hereditary vs environmental perspective. Am J Clin Nutr 1989, 50: 1244-59.
10. Tanner JM, Whitehouse RH. Clinical longitudinal standard of height, weight, height velocity, weight velocity and the stages of puberty. Arch Dis Child 1976, 51: 170-9.
11. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad V. Adiposity indices in children. Am J Clin Nutr 1982, 36: 178-84.
12. Tanner JM, Healy MJR, Goldstein H, Cameron N. Assessment of skeletal maturity and Prediction of Adult Height (TW3 Method). London: WB Saunders 2001.
13. Vignolo M, Naselli A, Magliano P, Di Battista E, Aicardi M, Aicardi G. Use of the new US90 standards forTW-RUS skeletal maturity scores in youths from the Italian population. Horm Res 1999, 51: 168-72.
14. Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD. Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab 1990, 70: 1330-3.
15. Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. Clin Endocrinol Metab 1997, 82: 2423-8.
16. Baroncelli GI, Bertelloni S, Sodini F, Saggese G. Lumbar bone mineral density at final height and prevalence of fractures in treated children with growth hormone deficiency. J Clin Endocrinol Metab 2002, 87: 3624-31.
17. Drake WM, Carroll PV, Maher KT, et al. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. J Clin Endocrinol Metab 2003, 88: 1658-63.
18. Saggese G, Baroncelli GI, Bertelloni S, Bersanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996, 81: 3077-83.